Democrats face backlash for opposing bipartisan legislation aimed at closing loopholes in U.S. drug laws taken advantage of by fentanyl traffickers. The HALT Fentanyl Act seeks to make the temporary Schedule I classification for fentanyl analogs permanent, but is opposed by some Democrats and a Soros-backed drug policy nonprofit.
Key Points
The HALT Fentanyl Act seeks to make the temporary Schedule I classification for fentanyl analogs permanent.
Parents who lost children to fentanyl overdoses are urging Congress to pass the Act to address the escalating death toll.
Supporters believe the Act will streamline research on fentanyl analogs and reduce bureaucratic hurdles for scientists.
Pros
The HALT Fentanyl Act aims to close loopholes in U.S. drug laws exploited by fentanyl traffickers.
Supporters believe the Act will help combat the opioid crisis and go after criminals flooding communities with deadly drugs.
Cons
Some Democrats and a Soros-backed drug policy nonprofit oppose the Act, claiming it will exacerbate mass incarceration and limit research on fentanyl analogs.
Opponents argue that the Act will create new mandatory minimum sentences for fentanyl-related substances and impede research on overdose medications.